Trial Condition(s):

Skin recovery

A study to gain information how well dexpanthenol dermal spray helps the skin to recover after a peeling in the external genital area of women

Bayer Identifier:

20507 Identifier:


EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure (peeling) in the intimate area of women.
After the peeling, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.

Inclusion Criteria
- Phototypes I and II according to the Fitzpatrick scale;
                - Participants willing to have peeling in the genital area to improve the general appearance of the skin and bleaching of spots.
Exclusion Criteria
- Pathologies and/or skin injuries, such as psoriasis, sensitive skin, skin cancer, atopic dermatitis or other medical criteria to be considered at the time of evaluation
                - Hyperpigmentation in the test area that interfere with the evaluation of possible reactions (vascular malformations, scars, increase of pilosity and large amount of nevi)
                - Pathologies and/or active skin injuries (local and/or disseminated) in the evaluation area

Trial Summary

Enrollment Goal
Trial Dates
Could I receive a placebo?
Bepantol® Derma Spray (BAY207543)
Accepts Healthy Volunteers

Where to Participate


Medcin Instituto da Pele

Sao Paulo, Brazil, 06023-070

Trial Design